Gloshell
Ingredients

Ingredient Dictionary

DEDM HYDANTOIN

Molecular structure

Definition

US FDA substance register · UNII 20Y07BBS8T · registered name DIETHYLOL DIMETHYL HYDANTOIN · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Inhibits microbial growthANTIMICROBIAL

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Names & identifiers

DEDM HYDANTOININCI디이디엠하이단토인Korean label name (MFDS standard)2,4-Imidazolidinedione, 1,3-bis(2-hydroxyethyl)-5,5-dimethyl-Synonym
CAS No.chemical registry number
26850-24-8
EC No.EU chemical inventory number
248-052-5
DTXSIDUS EPA chemical ID
DTXSID0067260
DTXCIDUS EPA compound ID
DTXCID9037581
IUPAC
1,3-Bis(2-hydroxyethyl)-5,5-dimethylimidazolidine-2,4-dione
Molecular formula
C9H16N2O4
Molecular weight
216.237 g/mol

Measured properties

Appearance
CBI, Other Solid

Values measured on the substance itself, not a specification for a commercial raw material.

Source: PubChem

What products actually use it for

What the 6 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Solvent2
  • Viscosity modifier1
  • Biocide1
  • Chemical reaction regulator1
  • Surfactant (surface active agent)1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

3 skin studies and 0 eye studies are on record.

Classed as low1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • SkinIrr2
    Skin Irritation · QSAR Predicted
  • SkinSens1
    Skin Sensitization · QSAR Predicted
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)

Source: US EPA CompTox dashboard

Linked databases 13